The lawsuit concerns smartwatches such as the Galaxy Watch 3, Galaxy Watch 4, Galaxy Watch 5, and Watch Active 2, which claim heart rate, breathing rate, depth and rhythm, body temperature, activity level, skin tone and blood pressure, blood oxygen saturation measurements, and heart failure There are infringements in technologies such as detection and measurement of outdoor temperature, humidity, and air quality.

It is learned from reports that Ki Chon, a professor at the University of Connecticut, met with Matthew Wiggins, a senior algorithm manager at the Samsung Strategy and Innovation Center in Boston in June 2015, and worked with Samsung on the development of smartwatches from 2016 to 2018.

However, the cooperation between the two parties stopped in 2018, and Samsung will continue to promote clinical trials and independently launch heart-related wearable devices.

Samsung received certification from the U.S. Food and Drug Administration (FDA) in September 2020 to release a health monitoring app that can be used on the Galaxy Watch 3 and Galaxy Watch Active 2.

The plaintiffs contend that Samsung’s subsequent Galaxy Watch features were based on Dr. Chun’s papers and publications.

The post Samsung sued by the agency for allegedly infringing 9 patents on Galaxy Smartwatch appeared first on TechGoing.